What is it about?
These children have matabolic problems affecting many systems and also bone quality and growth. This study evaluates baseline values of bone density in this disease and also differences related to genotype and treatment stratus.
Featured Image
Why is it important?
No other studies evaluating DXA in children with Gaucher dis.
Perspectives
Further studies are needed to put our results in time perspective. Specifically those who receive treatment
Ehud Lebel
Shaare Zedek Medical Center
Read the Original
This page is a summary of: Bone mineral density and lean muscle mass characteristics in children with Gaucher disease treated with enzyme replacement therapy or untreated, Blood Cells Molecules and Diseases, November 2016, Elsevier,
DOI: 10.1016/j.bcmd.2016.10.006.
You can read the full text:
Contributors
The following have contributed to this page
